Table 22a:
Prostate Cancer Detection by ERSPC Countries, Core Age Group (55–69 Years)
| ERSPC Participating Countries | ||||||||
|---|---|---|---|---|---|---|---|---|
| Netherlands | Belgium | Sweden | Finland | Italy | Spain | Switzerland | Total | |
| Randomization period | 1993–2000 | 1991–2003 | 1994 | 1996–1999 | 1996–2000 | 1996–1999 | 1998–2003 | |
| Median follow-up, years | 11.1 | 12.1 | 14.0 | 11.0 | 10.7 | 10.7 | 8.2 | 11.0 |
| Men randomized, n | 43,368 | 10,359 | 19,911 | 80,379 | 14,972 | 3,702 | 10,309 | 182,000 |
| Screen interval | 4 years | 4–7 years | 2 years | 4 years | 4 years | 4 years | 4 years | |
| Screen arm participants, n | 21,206 | 5,188 | 9,957 | 31,970 | 7,497 | 1,840 | 5,158 | 82,816 |
| Total PCs detected in screen arm | 2,487 | 504 | 1,139 | 2,838 | 394 | 88 | 497 | 7,938 |
| Screen detected, n | 2,040 | 214 | 896 | 1,631 | 202 | 78 | 394 | 5,455 |
| Interval or non-attender, n | 438 | 290 | 243 | 1,207 | 192 | 10 | 103 | 2,483 |
| Control arm participants, n | 21,162 | 5,171 | 9,954 | 48,409 | 7,475 | 1,862 | 5,151 | 99,184 |
| Total PCs detected in control arm | 1,152 | 405 | 715 | 3,175 | 267 | 33 | 237 | 5,984 |
Abbreviations: ERSPC, European Randomized Study of Screening for Prostate Cancer; n, number; PC, prostate cancer.
Source: Schroder et al, 2012. (55)